PD23-12 COMPARISON OF PERIOPERATIVE OUTCOMES BETWEEN HOLMIUM LASER ENUCLEATION OF THE PROSTATE AND ROBOTIC ASSISTED SIMPLE PROSTATECTOMY

Abstract

You have accessJournal of UrologyBenign Prostatic Hyperplasia: Surgical Therapy & New Technology III1 Apr 2017PD23-12 COMPARISON OF PERIOPERATIVE OUTCOMES BETWEEN HOLMIUM LASER ENUCLEATION OF THE PROSTATE AND ROBOTIC ASSISTED SIMPLE PROSTATECTOMY Mimi W. Zhang, Marawan M. El Tayeb, Michael S. Borofsky, Casey A. Dauw, Kristofer R. Wagner, Patrick S. Lowry, Erin T. Bird, Tillman C. Hudson, and James E. Lingeman Mimi W. ZhangMimi W. Zhang More articles by this author , Marawan M. El TayebMarawan M. El Tayeb More articles by this author , Michael S. BorofskyMichael S. Borofsky More articles by this author , Casey A. DauwCasey A. Dauw More articles by this author , Kristofer R. WagnerKristofer R. Wagner More articles by this author , Patrick S. LowryPatrick S. Lowry More articles by this author , Erin T. BirdErin T. Bird More articles by this author , Tillman C. HudsonTillman C. Hudson More articles by this author , and James E. LingemanJames E. Lingeman More articles by this author View All Author Informationhttps://doi.org/10.1016/j.juro.2017.02.1076AboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookTwitterLinked InEmail INTRODUCTION AND OBJECTIVES Simple prostatectomy is the standard surgical treatment for benign prostatic hypertrophy (BPH) in men with large prostates. There are increasing efforts to treat BPH with minimally invasive techniques including holmium laser enucleation of the prostate (HoLEP) and robotic assisted simple prostatectomy (RSP). Herein we compare perioperative outcomes for patients undergoing one of these two procedures. METHODS Patient demographics and perioperative outcomes were compared between 600 patients undergoing HoLEP and 32 patients undergoing RSP at two separate academic institutions between 2008 and 2015. RESULTS Patients undergoing HoLEP and RSP had comparable ages (71 vs. 71, p=0.96) and baseline AUA symptom scores (20 vs. 24, p= 0.21). There was no difference in mean specimen weight (96 vs. 110 g, p=0.15). Mean operative time was reduced in the HoLEP cohort (103 vs. 274 minutes, p<0.001). Patients undergoing HoLEP had lesser decreases in hemoglobin, decreased transfusions rates, shorter hospital stays, and decreased mean duration of catheterization. There was no difference in the rate of complications Clavien grade 3 or greater (p=0.33). CONCLUSIONS HoLEP and RSP are both efficacious treatments for large gland BPH. In expert hands HoLEP appears to have a favorable perioperative profile. Further studies are necessary to compare long-term efficacy, cost, and learning curve influences, especially as minimally invasive approaches become more widespread. © 2017FiguresReferencesRelatedDetails Volume 197Issue 4SApril 2017Page: e451 Advertisement Copyright & Permissions© 2017MetricsAuthor Information Mimi W. Zhang More articles by this author Marawan M. El Tayeb More articles by this author Michael S. Borofsky More articles by this author Casey A. Dauw More articles by this author Kristofer R. Wagner More articles by this author Patrick S. Lowry More articles by this author Erin T. Bird More articles by this author Tillman C. Hudson More articles by this author James E. Lingeman More articles by this author Expand All Advertisement Advertisement PDF downloadLoading ...